Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -33.58% | -2.18% | |||
| Gross Profit | 33.58% | 2.18% | |||
| SG&A Expenses | -13.21% | 0.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.97% | -1.07% | |||
| Operating Income | 24.97% | 1.07% | |||
| Income Before Tax | 25.25% | 1.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.25% | 1.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.25% | 1.80% | |||
| EBIT | 24.97% | 1.07% | |||
| EBITDA | 25.37% | 1.03% | |||
| EPS Basic | 26.00% | 14.40% | |||
| Normalized Basic EPS | 25.99% | 14.40% | |||
| EPS Diluted | 26.00% | 14.40% | |||
| Normalized Diluted EPS | 25.99% | 14.40% | |||
| Average Basic Shares Outstanding | 1.02% | 14.72% | |||
| Average Diluted Shares Outstanding | 1.02% | 14.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||